Key opportunities in the targeted drug delivery market include advances in precision medicine, next-gen carrier tech, strategic partnerships, resilient supply chains, and patient-centric design.
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results